Logo image of CLVT

CLARIVATE PLC (CLVT) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:CLVT - JE00BJJN4441 - Common Stock

3.52 USD
-0.04 (-1.12%)
Last: 12/11/2025, 3:48:02 PM
Fundamental Rating

3

Overall CLVT gets a fundamental rating of 3 out of 10. We evaluated CLVT against 87 industry peers in the Professional Services industry. CLVT has a bad profitability rating. Also its financial health evaluation is rather negative. CLVT has a bad growth rate and is valued cheaply.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

CLVT had positive earnings in the past year.
CLVT had a positive operating cash flow in the past year.
CLVT had negative earnings in each of the past 5 years.
CLVT had a positive operating cash flow in each of the past 5 years.
CLVT Yearly Net Income VS EBIT VS OCF VS FCFCLVT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 -1B -2B -3B -4B

1.2 Ratios

CLVT's Return On Assets of -3.53% is on the low side compared to the rest of the industry. CLVT is outperformed by 64.37% of its industry peers.
Looking at the Return On Equity, with a value of -8.08%, CLVT is doing worse than 64.37% of the companies in the same industry.
CLVT has a Return On Invested Capital of 1.46%. This is in the lower half of the industry: CLVT underperforms 62.07% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CLVT is significantly below the industry average of 12.13%.
Industry RankSector Rank
ROA -3.53%
ROE -8.08%
ROIC 1.46%
ROA(3y)-14.17%
ROA(5y)-9.23%
ROE(3y)-29.57%
ROE(5y)-18.95%
ROIC(3y)1.87%
ROIC(5y)1.34%
CLVT Yearly ROA, ROE, ROICCLVT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40

1.3 Margins

The Operating Margin of CLVT (7.19%) is better than 60.92% of its industry peers.
CLVT's Operating Margin has improved in the last couple of years.
CLVT has a better Gross Margin (65.76%) than 81.61% of its industry peers.
CLVT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 7.19%
PM (TTM) N/A
GM 65.76%
OM growth 3Y19.56%
OM growth 5Y51.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y0.48%
CLVT Yearly Profit, Operating, Gross MarginsCLVT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CLVT is destroying value.
Compared to 1 year ago, CLVT has more shares outstanding
Compared to 5 years ago, CLVT has more shares outstanding
Compared to 1 year ago, CLVT has a worse debt to assets ratio.
CLVT Yearly Shares OutstandingCLVT Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
CLVT Yearly Total Debt VS Total AssetsCLVT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

Based on the Altman-Z score of -0.46, we must say that CLVT is in the distress zone and has some risk of bankruptcy.
CLVT has a Altman-Z score of -0.46. This is amonst the worse of the industry: CLVT underperforms 81.61% of its industry peers.
CLVT has a debt to FCF ratio of 13.18. This is a negative value and a sign of low solvency as CLVT would need 13.18 years to pay back of all of its debts.
The Debt to FCF ratio of CLVT (13.18) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.90 indicates that CLVT is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.90, CLVT is not doing good in the industry: 67.82% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF 13.18
Altman-Z -0.46
ROIC/WACC0.19
WACC7.52%
CLVT Yearly LT Debt VS Equity VS FCFCLVT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

CLVT has a Current Ratio of 0.87. This is a bad value and indicates that CLVT is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of CLVT (0.87) is worse than 80.46% of its industry peers.
A Quick Ratio of 0.87 indicates that CLVT may have some problems paying its short term obligations.
With a Quick ratio value of 0.87, CLVT is not doing good in the industry: 80.46% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.87
Quick Ratio 0.87
CLVT Yearly Current Assets VS Current LiabilitesCLVT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

3

3. Growth

3.1 Past

CLVT shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -6.58%.
The Earnings Per Share has been growing slightly by 1.87% on average over the past years.
The Revenue has decreased by -2.96% in the past year.
The Revenue has been growing by 21.28% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-6.58%
EPS 3Y1.87%
EPS 5YN/A
EPS Q2Q%-5.26%
Revenue 1Y (TTM)-2.96%
Revenue growth 3Y10.85%
Revenue growth 5Y21.28%
Sales Q2Q%0.14%

3.2 Future

Based on estimates for the next years, CLVT will show a decrease in Earnings Per Share. The EPS will decrease by -0.43% on average per year.
The Revenue is expected to grow by 0.37% on average over the next years.
EPS Next Y-9.56%
EPS Next 2Y-3.74%
EPS Next 3Y0.97%
EPS Next 5Y-0.43%
Revenue Next Year-4.38%
Revenue Next 2Y-3.34%
Revenue Next 3Y-1.55%
Revenue Next 5Y0.37%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CLVT Yearly Revenue VS EstimatesCLVT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B 2B 2.5B
CLVT Yearly EPS VS EstimatesCLVT Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0.2 0.4 0.6 0.8

7

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 4.96 indicates a rather cheap valuation of CLVT.
Based on the Price/Earnings ratio, CLVT is valued cheaply inside the industry as 93.10% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 26.59. CLVT is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 5.13, which indicates a rather cheap valuation of CLVT.
CLVT's Price/Forward Earnings ratio is rather cheap when compared to the industry. CLVT is cheaper than 93.10% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.80. CLVT is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 4.96
Fwd PE 5.13
CLVT Price Earnings VS Forward Price EarningsCLVT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

86.21% of the companies in the same industry are more expensive than CLVT, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, CLVT is valued cheaper than 91.95% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.95
EV/EBITDA 6.9
CLVT Per share dataCLVT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3.74%
EPS Next 3Y0.97%

0

5. Dividend

5.1 Amount

CLVT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CLARIVATE PLC

NYSE:CLVT (12/11/2025, 3:48:02 PM)

3.52

-0.04 (-1.12%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)10-29 2025-10-29/bmo
Earnings (Next)02-17 2026-02-17/bmo
Inst Owners58.2%
Inst Owner ChangeN/A
Ins Owners0.88%
Ins Owner Change-4.67%
Market Cap2.33B
Revenue(TTM)2.50B
Net Income(TTM)-396.00M
Analysts72
Price Target4.95 (40.63%)
Short Float %12.35%
Short Ratio9.78
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.06
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.44%
Min EPS beat(2)1.75%
Max EPS beat(2)9.13%
EPS beat(4)4
Avg EPS beat(4)7.7%
Min EPS beat(4)1.61%
Max EPS beat(4)18.32%
EPS beat(8)7
Avg EPS beat(8)5.56%
EPS beat(12)11
Avg EPS beat(12)8.56%
EPS beat(16)15
Avg EPS beat(16)8.83%
Revenue beat(2)2
Avg Revenue beat(2)5.23%
Min Revenue beat(2)3.36%
Max Revenue beat(2)7.11%
Revenue beat(4)3
Avg Revenue beat(4)2.75%
Min Revenue beat(4)-1.53%
Max Revenue beat(4)7.11%
Revenue beat(8)3
Avg Revenue beat(8)0.2%
Revenue beat(12)5
Avg Revenue beat(12)0.03%
Revenue beat(16)5
Avg Revenue beat(16)-0.64%
PT rev (1m)-4.9%
PT rev (3m)-4.9%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-5.15%
EPS NY rev (1m)0.51%
EPS NY rev (3m)0.17%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.19%
Revenue NY rev (1m)0.65%
Revenue NY rev (3m)2.09%
Valuation
Industry RankSector Rank
PE 4.96
Fwd PE 5.13
P/S 0.93
P/FCF 6.95
P/OCF 3.82
P/B 0.47
P/tB N/A
EV/EBITDA 6.9
EPS(TTM)0.71
EY20.17%
EPS(NY)0.69
Fwd EY19.48%
FCF(TTM)0.51
FCFY14.4%
OCF(TTM)0.92
OCFY26.2%
SpS3.78
BVpS7.41
TBVpS-7.27
PEG (NY)N/A
PEG (5Y)N/A
Graham Number10.88
Profitability
Industry RankSector Rank
ROA -3.53%
ROE -8.08%
ROCE 1.85%
ROIC 1.46%
ROICexc 1.51%
ROICexgc N/A
OM 7.19%
PM (TTM) N/A
GM 65.76%
FCFM 13.4%
ROA(3y)-14.17%
ROA(5y)-9.23%
ROE(3y)-29.57%
ROE(5y)-18.95%
ROIC(3y)1.87%
ROIC(5y)1.34%
ROICexc(3y)1.93%
ROICexc(5y)1.38%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)2.36%
ROCE(5y)1.69%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y62.12%
ROICexc growth 5Y45.61%
OM growth 3Y19.56%
OM growth 5Y51.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y0.48%
F-Score5
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF 13.18
Debt/EBITDA 4.73
Cap/Depr 36.43%
Cap/Sales 10.98%
Interest Coverage 250
Cash Conversion 65.3%
Profit Quality N/A
Current Ratio 0.87
Quick Ratio 0.87
Altman-Z -0.46
F-Score5
WACC7.52%
ROIC/WACC0.19
Cap/Depr(3y)37.07%
Cap/Depr(5y)34.15%
Cap/Sales(3y)10.18%
Cap/Sales(5y)9.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-6.58%
EPS 3Y1.87%
EPS 5YN/A
EPS Q2Q%-5.26%
EPS Next Y-9.56%
EPS Next 2Y-3.74%
EPS Next 3Y0.97%
EPS Next 5Y-0.43%
Revenue 1Y (TTM)-2.96%
Revenue growth 3Y10.85%
Revenue growth 5Y21.28%
Sales Q2Q%0.14%
Revenue Next Year-4.38%
Revenue Next 2Y-3.34%
Revenue Next 3Y-1.55%
Revenue Next 5Y0.37%
EBIT growth 1Y-30.83%
EBIT growth 3Y32.53%
EBIT growth 5Y83.55%
EBIT Next Year9631.72%
EBIT Next 3Y360.12%
EBIT Next 5Y153.39%
FCF growth 1Y-24.35%
FCF growth 3Y16.61%
FCF growth 5Y48.48%
OCF growth 1Y-11.63%
OCF growth 3Y25.93%
OCF growth 5Y40.62%

CLARIVATE PLC / CLVT FAQ

What is the fundamental rating for CLVT stock?

ChartMill assigns a fundamental rating of 3 / 10 to CLVT.


Can you provide the valuation status for CLARIVATE PLC?

ChartMill assigns a valuation rating of 7 / 10 to CLARIVATE PLC (CLVT). This can be considered as Undervalued.


Can you provide the profitability details for CLARIVATE PLC?

CLARIVATE PLC (CLVT) has a profitability rating of 3 / 10.


Can you provide the PE and PB ratios for CLVT stock?

The Price/Earnings (PE) ratio for CLARIVATE PLC (CLVT) is 4.96 and the Price/Book (PB) ratio is 0.47.


Can you provide the expected EPS growth for CLVT stock?

The Earnings per Share (EPS) of CLARIVATE PLC (CLVT) is expected to decline by -9.56% in the next year.